Newswise — AstraZeneca and the American Cancer Society today announced a strategic collaboration to significantly extend the reach of the Society’s innovative Patient Navigator Program – an initiative to assist individual cancer patients in negotiating the health care system. With major support from AstraZeneca, the American Cancer Society will accelerate development of at least 50 new Patient Navigator Program sites over the next five years in communities throughout the United States. The first three sites to launch are Seattle Cancer Care Alliance in Seattle, Washington; Helen F.